This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Mahesh Raundhal: Innovator in Anemia Treatment
Introduction
Mahesh Raundhal is a notable inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of red blood cell disorders. His innovative approach has the potential to improve the lives of many patients suffering from anemia.
Latest Patents
Raundhal holds a patent for "Methods of treating anemia in myelodysplastic syndromes." This invention focuses on methods for treating red blood cell disorders, such as myelodysplastic syndromes (MDS) and anemia, by down-regulating IL-22 signaling. This groundbreaking work highlights his commitment to advancing medical science.
Career Highlights
Mahesh Raundhal is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to work on innovative solutions for complex medical challenges. His dedication to research and development in the field of hematology is commendable.
Conclusion
Mahesh Raundhal's contributions to the treatment of anemia through his patented methods demonstrate his innovative spirit and commitment to improving patient care. His work at the Dana-Farber Cancer Institute Inc. positions him as a key figure in the ongoing fight against blood disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
